EPHA7 and gastric carcinoma: Wang J [19, 20]confirmed hypermethylation of the promoter of EphA7 in gastric carcinoma since EphA7 expression was restored after demethylation treatment with 5-aza-2-deoxycytidine (5-aza-dc).